Food and Drug Administration Modernization Act of 1997

E165705

The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Statements (48)

Predicate Object
instanceOf United States federal statute
health law
aimedAt enhancing patient access to experimental therapies
modernization of FDA
speeding approval of drugs
speeding approval of medical devices
streamlining FDA regulatory procedures
amends Federal Food, Drug, and Cosmetic Act
appliesTo Food and Drug Administration
authorizes FDA to accept user fees for device review
FDA to rely on third-party review for some devices
dissemination of peer-reviewed journal articles on off-label uses under conditions
country United States of America
surface form: United States
enactedBy United States Congress
establishes framework for risk-based regulation of devices
procedures for meetings and dispute resolution with FDA
requirements for clinical trial registration in certain contexts
goal improve patient access to new therapies
maintain standards for safety and effectiveness
reduce regulatory burden on industry
includes provisions on device tracking and postmarket surveillance
provisions on health claims for foods
provisions on pharmacy compounding
provisions on radiopharmaceuticals
jurisdiction federal regulation of food and drugs in the United States
providesFor expanded access to investigational devices
expanded access to investigational drugs
fast track designation for certain drugs
postmarketing studies requirements
use of surrogate endpoints in approval
regulates biological products approval
drug approval process
medical device approval process
relatedTo Food and Drug Administration Safety and Innovation Act of 2012
surface form: Food and Drug Administration Safety and Innovation Act

Prescription Drug User Fee Act of 1992
surface form: Prescription Drug User Fee Act
shortName FDAMA
signedBy Bill Clinton
signingPresident Bill Clinton
subject biologics regulation
clinical trials
drug regulation
fast track drug approval
medical device regulation
off-label information dissemination
pediatric studies of drugs
pharmacy compounding
user fees
timePeriod 1990s health policy reforms in the United States

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

Federal Food, Drug, and Cosmetic Act amendedBy Food and Drug Administration Modernization Act of 1997
FDC Act amendedBy Food and Drug Administration Modernization Act of 1997
Orphan Drug Act of 1983 amendedBy Food and Drug Administration Modernization Act of 1997
this entity surface form: FDA Modernization Act of 1997
Prescription Drug User Fee Act of 1992 relatedTo Food and Drug Administration Modernization Act of 1997